Log in to save to my catalogue

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel sy...

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel sy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cf842839bb364726b60a6e8eff1211e7

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study

About this item

Full title

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study

Author / Creator

Publisher

India: Wolters Kluwer India Pvt. Ltd

Journal title

Saudi journal of gastroenterology, 2021-05, Vol.27 (3), p.136-143

Language

English

Formats

Publication information

Publisher

India: Wolters Kluwer India Pvt. Ltd

More information

Scope and Contents

Contents

Background: Drotaverine and Mebeverine are used for alleviating the pain of IBS, but the evidence for their efficacy is scarce. In this randomised control study, we evaluated and compared their efficacy in improving severity, frequency of pain and its associated symptoms.
Methods: Patients fulfilling the ROME III criteria of IBS were evaluated i...

Alternative Titles

Full title

Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cf842839bb364726b60a6e8eff1211e7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cf842839bb364726b60a6e8eff1211e7

Other Identifiers

ISSN

1319-3767

E-ISSN

1998-4049

DOI

10.4103/sjg.SJG_266_20

How to access this item